Behavioral Neuropharmacology

It is the study of drug dependence and how drug addiction affects the human mind, Anxiety and Autism, Measuring neural activity in Drug abuse, Alcoholism- tolerance to and physical dependence, and properties are mediated through its effects on dopamine neurons in the mesolimbic reward pathway, which connects the ventral tegmental area to the nucleus accumbens, Post-traumatic stress disorder and borderline personality disorder, clinical depression and enhanced treatments.

The global autism spectrum disorders (ASD) market was valued at $346.2 million in 2013 and $360.9 million in 2014. This market is expected to grow to $412.7 million by 2019, a compound annual growth rate (CAGR) of 2.7%.

Drugs of abuse alter the way people think, feel, and behave by disrupting neurotransmission, the process of communication between brain cells. Drug dependence and addiction are features of a brain disease caused by drugs' cumulative impacts on neurotransmission. However, terrifying events can cause Post-traumatic stress disorder (PTSD). Symptoms of PTSD may include flashbacks, nightmares and severe anxiety, as well as uncontrollable thoughts about the event.

  • Anxiety and Autism
  • Measuring neural activity in drug abuse
  • Alcoholism- tolerance to and physical dependence
  • Post-traumatic stress disorder and borderline personality disorder
  • Clinical depression and enhanced treatments

Related Conference of Behavioral Neuropharmacology

Oct 31- Nov 02, 2016

5th International Conference on Forensic Research & Technology

San Francisco, California, USA
Nov 07-09, 2016

4th International Pharma & Clinical Pharmacy Congress

Las Vegas, Nevada, USA
Nov 07-09, 2016

4th International Pharma & Clinical Pharmacy Congress

Las Vegas, Nevada, USA
April 17-18, 2017

8th Global Pharmacovigilance & Drug Safety Summit

Bali, Indonesia
May 08-10, 2017

10th Asia-Pacific Pharma Congress

May 15-17, 2017

7th European Biosimilars Congress

Munich, Germany
July 10-12, 2017

9th Annual European Pharma Congress

Madrid, Spain
July 17-19, 2017

International Conference on Pigmentary Disorders

Melbourne, Australia
July 17-19, 2017

9th World Congress on BA/BE Studies and Biowaivers

Melbourne, Australia
July 24-26, 2017

8th World Congress on Pharmacology and Toxicology

Melbourne, Australia
July 31-Aug 02, 2017

7th Global Experts Meeting on Neuropharmacology

Milan, Italy
August 03-04, 2017

4th International Conference and Exhibition on Pain Medicine

San Francisco, USA
August 07-09, 2017

9th World Congress on Pharmacology

Paris, France
August 17-18, 2017

11th Annual Global Pharma Summit

San Francisco, USA
April 27-28, 2017

5th International Pharmacy Conference

Las Vegas, USA
Aug 21-22, 2017

Global Summit on Emerging Orphan Drugs and  Drug Abuse

San Francisco, USA
September 11-13, 2017

World Congress on Biotherapeutics

Dallas, USA
September 14-16, 2017

Immunology World

Amsterdam, Netherlands
September 18-19, 2017

International Conference on Next Generation Nanotechnology

Jackson Ville, USA
Sep 25-27, 2017

10th Pharmacovigilance Congress

Jackson Ville, USA
Sep 25-27, 2017

8th Annual Pharmaceutical Analysis Congress

Vienna, Austria
Sep 25-27, 2017

12th Annual Pharma Middle East Congress

Dubai, UAE
October 16-18, 2017

World Congress on Natural Products Chemistry and Research

Budapest, Hungary
October 19-21, 2017

9th Annual Congress on Drug Formulation & Drug Design

Seoul, South Korea
October 23-25, 2017

International Conference on Biotech Pharmaceuticals

Paris, France
September 11-13, 2017

4th International Conference on Clinical Trials

San Antonio, USA

Behavioral Neuropharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in